Efficacy and Safety of Clopidogrel With and Without a Proton Pump Inhibitor: A Systematic Review and Meta‐Analysis
Basic & Clinical Pharmacology & Toxicology · 2025-08 · 137 (2)
DOI: 10.1111/bcpt.70087 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, online erschienen am 21.07.2025. Verfasst von Magnus A B Axelsson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden. Hauptthemen laut MEDLINE: Clopidogrel, Proton Pump Inhibitors, Platelet Aggregation Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Swedish state under the ALF agreement between the Swedish government and the county councils, Swedish Research Council, Vetenskapsrådet.
Abstract (Originalsprache)
Classifications of drug interaction alerts regarding clopidogrel and a proton pump inhibitor (PPI) differ between knowledge resources. In this systematic review, Medline, Embase, and the Cochrane Library were searched for randomized controlled trials (RCTs) applying PICO criteria: P = patients on clopidogrel; I = intervention: PPI (subgroup: [es]omeprazole); C = comparison: no PPI (C1) or a PPI other than (es)omeprazole (C2); O = outcomes, main: a composite of cardiovascular events (efficacy); also: overt gastrointestinal bleeding (safety). Fourteen RCTs fulfilled the PICO criteria, five without high risk of bias and with at least one clinical event per study arm. Regarding efficacy with or without a PPI, the pooled risk ratio (RR) and risk difference (RD) were 1.08 (95% confidence interval (CI) 0.78; 1.50) and 0.2 percentage points (95% CI −0.9; 1.2), respectively (four RCTs; 4341 patients [96% also used aspirin, 98% receiving I used (es)omeprazole]; moderate certainty evidence). Regarding safety, the RR and RD were 0.13 (95% CI 0.03; 0.59) and −0.7 percentage points (95% CI −1.1; −0.3), respectively (one RCT; 3761 patients; moderate certainty evidence). The available evidence did not allow conclusions regarding omeprazole versus pantoprazole. In conclusion, concurrent use of a PPI probably does not largely affect clopidogrel efficacy, but probably reduces the risk of overt gastrointestinal bleeding.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Clinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.
- Department of Pharmacology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Department of Clinical Pharmacology, Sahlgrenska University Hospital, Gothenburg, Sweden.
- Department of Laboratory Medicine/Clinical Pharmacology, Karolinska Institute, Stockholm, Sweden.
- Department of Clinical Pharmacology, Medical Diagnostics, Karolinska University Hospital, Stockholm, Sweden.
- Center for Health Technology Assessment, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.
ORCID-Profile: Magnus A B Axelsson, Naldy Parodi López, Eva Wikström Jonsson, Susanna M Wallerstedt
Förderung
- Swedish state under the ALF agreement between the Swedish government and the county councils
- Swedish Research Council
- Vetenskapsrådet
Zitieren
APA
Axelsson, M. A. B., Parodi López, N., Wikström Jonsson, E., & Wallerstedt, S. M. (2025). Efficacy and Safety of Clopidogrel With and Without a Proton Pump Inhibitor: A Systematic Review and Meta‐Analysis. Basic & Clinical Pharmacology & Toxicology, 137(2). https://doi.org/10.1111/bcpt.70087
Vancouver
Axelsson MAB, Parodi López N, Wikström Jonsson E, Wallerstedt SM. Efficacy and Safety of Clopidogrel With and Without a Proton Pump Inhibitor: A Systematic Review and Meta‐Analysis. Basic & Clinical Pharmacology & Toxicology. 2025;137(2). doi:10.1111/bcpt.70087
BibTeX
@article{Axelsson2025,
author = {Axelsson, Magnus A B and Parodi López, Naldy and Wikström Jonsson, Eva and Wallerstedt, Susanna M},
title = {Efficacy and Safety of Clopidogrel With and Without a Proton Pump Inhibitor: A Systematic Review and Meta‐Analysis},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2025},
volume = {137},
number = {2},
doi = {10.1111/bcpt.70087}
}
EUVIMED